NEW YORK – Harvard University spinout NanoMosaic is looking to tackle the proteomics research market with its label-free biosensing system.
The Woburn, Massachusetts-based company is planning a beta rollout of its platform, which uses arrays of silicon "nanoneedles" functionalized with antibodies or other affinity reagents to detect and quantify proteins. According to Qimin Quan, NanoMosaic's co-founder and CSO, the system can measure analytes over a larger dynamic range than existing proteomic technologies and at considerably lower cost.